Illumina
ILMN
192.82
-7.84
-3.90%
Illumina
US · ILMN
#539 by market cap
Listed 1970
192.82
-7.84
-3.90%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
3 1
■ Upgrades■ Downgrades
- 3 upgrades vs 1 downgrade among tracked analyst rating changes.
- The single most recent change was actually a downgrade (CCORF moved from Buy to Hold on 2026-10-30), though the broader window skews toward upgrades.
Analyst consensus 15 analysts
Buy
Avg price target 265.73 +37.8%
Price target rangecurrent 192.82
Low200.00
Avg265.73
High310.00
Buy 53%
Hold 27%
Sell 20%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-18 | Bernstein | -- | Hold | 250.00 |
| 2026-11-13 | Bernstein | -- | Hold | -- |
| 2026-11-05 | Baird | -- | Hold | 236.00 |
| 2026-11-02 | Citi | -- | Sell | 210.00 |
| 2026-10-30 | CCORF | -- | Hold | 300.00 |
| 2026-10-30 | Piper Sandler | -- | Buy | 305.00 |
| 2026-10-30 | Stifel | -- | Buy | 300.00 |
| 2026-10-30 | Barclays | -- | Sell | 200.00 |
| 2026-10-30 | J.P. Morgan | -- | Buy | 300.00 |
| 2026-10-29 | BofA Securities | -- | Sell | 200.00 |
| 2026-10-29 | Guggenheim | -- | Buy | 305.00 |
| 2026-10-29 | RBC Capital | -- | Buy | 310.00 |
| 2026-10-26 | Barclays | -- | Sell | 200.00 |
| 2026-10-23 | Stephens | -- | Hold | 275.00 |
| 2026-10-19 | CCORF | -- | Buy | 300.00 |
| 2026-10-16 | J.P. Morgan | -- | Buy | 320.00 |
| 2026-10-09 | BofA Securities | -- | Sell | 168.00 |
| 2026-10-07 | Barclays | -- | Sell | 200.00 |
| 2026-10-04 | RBC Capital | -- | Buy | 310.00 |
| 2026-10-01 | Guggenheim | -- | Buy | 305.00 |
| 2026-09-29 | Leerink Partners | -- | Buy | 300.00 |
| 2026-09-28 | Piper Sandler | -- | Buy | 305.00 |
| 2026-09-15 | Stifel | -- | Buy | 225.00 |
| 2026-09-11 | CCORF | -- | Hold | -- |
| 2026-09-09 | Bernstein | -- | Hold | 215.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-30 | CCORF | Buy → Hold | 300.00 |
| 2026-10-19 | CCORF | Hold → Buy | 300.00 |
| 2026-09-09 | UBS | Hold → Buy | 260.00 |
| 2026-06-10 | J.P. Morgan | Hold → Buy | 185.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-29 | After close | ±11.97% | -18.64% (beat) |
| 2026/Q2 | 2026-07-30 | After close | ±10.23% | +0.00% (in line) |
| 2026/Q1 | 2026-04-30 | After close | ±8.67% | +7.13% (in line) |
| 2025/Q4 | 2026-02-05 | After close | ±9.65% | -10.40% (beat) |
| 2025/Q3 | 2025-10-30 | After close | ±11.16% | +24.78% (beat) |
| 2025/Q2 | 2025-07-31 | After close | ±10.94% | -7.84% (in line) |
| 2025/Q1 | 2025-05-08 | After close | ±11.04% | -4.80% (in line) |
| 2024/Q4 | 2025-02-06 | After close | ±8.74% | -9.56% (beat) |
| 2024/Q3 | 2024-11-04 | After close | ±8.45% | +0.96% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±10.27% | +4.07% (in line) |
| 2024/Q1 | 2024-05-02 | After close | ±9.29% | -4.89% (in line) |
| 2023/Q4 | 2024-02-08 | After close | ±9.56% | -3.83% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Illumina discussion 0 comments